Strategic Overview

Intelligenome is developing CRISPR-based diagnostic solutions for TB using innovative gene-editing technology for high-quality molecular diagnostics.

Innovation Portfolio

CRISPR-TB
Category: DIAGNOSIS Stage: Commercial

Innovative diagnostic solution.

Decent. Mol. Blood
Lab-in-A Tube
Category: DIAGNOSIS Stage: Late Stage

Innovative diagnostic solution.

Decent. Mol. Blood

Key Milestones

Pioneering CRISPR-based TB diagnostics
Developing point-of-care solutions
Blood-based testing innovation